ESC MedTech completes Series A financing raising tens of millions, providing drug delivery device system solutions

On January 21, ESC MedTech announced the successful closure of a Series A funding round, raising tens of millions. This capital will be deployed to enhance the company's core industrial competitiveness by accelerating production cycles, reducing costs, and improving efficiency. Furthermore, it will drive integration across the upstream and downstream ecosystem and advance intelligent manufacturing upgrades. These comprehensive initiatives are designed to ensure that its pharmaceutical partners can effectively navigate the industry's mounting cost challenges.

ESC MedTech Founder Zhang Lijie stated: "We thank ALAN AMC for recognizing ESC MedTech and appreciate our longstanding shareholder Lizhong Capital's continuous support. Since establishment, ESC MedTech has adhered to the business philosophy of 'With reverence in heart, creating industry excellence,' consistently serving customers with pharmaceutical professionals' humility and rigor. We persist in integrity-based innovation with core product principles of 'Ease of use, Safety, Comfort' focused on patient experience. After over two years of development, ESC MedTech's systematic solutions rank among the top in China's brand landscape in delivery case volume and reputation, becoming an industry benchmark model. Moving forward, ESC MedTech will accelerate internationalization and continue creating value to repay investors' trust."

Dr. Wu Ping of ALAN AMC stated: "With rapid biopharmaceutical development, self-administration will become an important future delivery method. Through deep communication with ESC MedTech, we highly recognize their expertise in drug delivery devices. Their extreme pursuit of technological innovation, deep practice of customer value, and long-term enterprise planning demonstrate outstanding responsibility. The team's patent layout, lean production, and precision manufacturing capabilities combine innovation and execution, making us confident in future collaboration. We will continue empowering the team to jointly create greater value."

ESC MedTech specializes in providing drug delivery device system solutions, covering auto-injectors, cartridge-based pen injector, safety devices, OBDS, and supporting industrial chains. Services include: appearance customization, engineering verification, design validation, sample production, commercial production, injector pen testing solutions, injector pen assembly solutions, and regulatory submission services.